Quadrant Capital Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,972
| Closed | -$22.5K | – | 1580 |
|
|
2025
Q1 | $22.5K | Buy |
2,972
+2,731
| +1,133% | +$20.7K | ﹤0.01% | 2003 |
|
|
2024
Q4 | $2.94K | Sell |
241
-20
| -8% | -$244 | ﹤0.01% | 2442 |
|
|
2024
Q3 | $4.37K | Sell |
261
-27
| -9% | -$452 | ﹤0.01% | 2349 |
|
|
2024
Q2 | $5.02K | Sell |
288
-18
| -6% | -$314 | ﹤0.01% | 2287 |
|
|
2024
Q1 | $5.22K | Buy |
306
+65
| +27% | +$1.11K | ﹤0.01% | 2303 |
|
|
2023
Q4 | $2.46K | Buy |
+241
| New | +$2.46K | ﹤0.01% | 2436 |
|
|
2023
Q1 | – | Sell |
-631
| Closed | -$6.66K | – | 2728 |
|
|
2022
Q4 | $6.66K | Buy |
+631
| New | +$6.66K | ﹤0.01% | 2126 |
|